NIVF
NewGenIvf Group LimitedNASDAQHealthcare$2.13+0.00%ClosedMarket Cap: $1.2M
As of 2026-04-07
Valuation
View DetailsP/E (TTM)
0.08
PEG
0.00
P/B
0.04
P/S
0.47
EV/EBITDA
0.38
DCF Value
$0.79
FCF Yield
-525.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
18.7%
Operating Margin
-140.9%
Net Margin
653.9%
ROE
117.2%
ROA
47.0%
ROIC
-10.5%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $1.3M | $16.8M | $28.60 |
| Q4 2024 | $1.3M | $-108.0K | $-4.60 |
| FY 2024 | $5.4M | $-525.0K | $-22.31 |
| Q3 2024 | $1.5M | $-19.9K | $-1.31 |
Analyst Ratings
View AllConsensus
—
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
0 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell
Trading Activity
Insider Trades
View AllSiu Wing Fung Alfreddirector, officer: Chairman & CEO
SellTue Mar 31
Fong Hei Yue Tinadirector, officer: Chief Marketing Officer
SellFri Mar 27
Ching Chan Florianna Ann Chi Wandirector:
SellFri Mar 27
Tam Chun Wadirector:
SellFri Mar 27
Au Hok Man Jeffersondirector:
SellTue Mar 24
Company Info
Sector
Healthcare
Industry
—
Country
TH
Exchange
NASDAQ
Beta
-0.01
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.